概括
新的杀虫剂化合物,包括类同类物和新型,表现出类似于甲酸的活性. 这些化合物与piperonyl butoxide表现出协同作用,并阻断神经刺激性,类似于allethrin.
科学领域:
- 有机化学 有机化学
- 杀虫剂开发 杀虫剂开发
- 神经毒理学 神经毒理学
背景情况:
- 甲是一种主要的杀虫剂类别,以其有效性和相对较低的哺乳动物毒性而闻名.
- 甲酸的杀虫活性通常与特定的化学结构有关,特别是环基酸的.
- 皮佩罗尼尔丁氧化物是一种常见的协同剂,通过抑制代谢排毒来增强某些杀虫剂的疗效.
研究的目的:
- 为了研究新型杀虫剂化合物对甲状腺类活性.
- 为了确定这些化合物是否与piperonyl butoxide表现出协同作用.
- 为了阐明神经刺激阻塞的机制,与阿莱特林相比.
主要方法:
- 合成一个类型的阿莱特林:1-(4-阿莱特罗尼尔) - 乙烯基-2,2-二甲基-3-异布丁cyclopropane.
- 用各种碳素酸对5--3基甲醇进行化:2,2,3,3-四甲基cyclopropanecarboxylic 酸,2,2,3,3-四甲基laziridinecarboxylic 酸,以及N,N-diisopropylcarbamic 酸.
- 评价杀虫活性,与piperonyl butoxide的协同作用,以及神经刺激性阻塞.
主要成果:
- 合成的类同类和新型 Ester 显示出杀虫性能.
- 这些化合物与piperonyl butoxide表现出协同作用,这表明它们与传统的铁类药物有共同的代谢途径.
- 这些化合物通过类似于甲状腺杀虫剂allethrin的机制阻止了神经刺激.
结论:
- 像甲类杀虫剂的杀虫活性不仅仅局限于环烯碳酸的 Ester.
- 新的化学支架,如类类似物和不同的类型,可以具有强大的杀虫性能.
- 这些发现扩大了化合物的结构多样性,在昆虫控制中具有潜在的应用.
相关概念视频
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Basicity of Heterocyclic Aromatic Amines
Heterocyclic amines, where the N atom is a part of an alicyclic system, are similar in basicity to alkylamines. Interestingly, the heterocyclic amine having a nitrogen atom as part of an aromatic ring has much less basicity than its corresponding alicyclic counterpart. For this reason, as presented in Figure 1, piperidine (pKb = 2.8) is significantly more basic than pyridine (pKb = 8.8).
Carboxylic Acid Derivatives: Overview
Carboxylic acid derivatives are formed by replacing the hydroxyl group of carboxylic acids with a different functional group. The most common carboxylic acid derivatives are:
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...

